FDA approves Lanett’s muscle relaxant drug: 3 things to know

The Food and Drug Administration approved Philadelphia-based Lannett’s metaxalone tablets.

Advertisement

Here are three things to know.

1. The drug is a muscle relaxant intended to treat patients with acute, painful musculoskeletal conditions.

2. Metaxalone tablets are a generic version of King Pharmaceuticals’ drug Skelaxin.

3. Lannett plans to launch the drug this quarter.

More articles on supply chain:

Court orders contracted pilots for Amazon, DHL to return to work after strike
Medisafe and TimerCap launch Bluetooth-enabled pill bottle to track medication adherence
Demand for durable manufactured goods rose 4.8% in October — largest jump in a year

 

Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit

Advertisement

Next Up in Supply Chain

Advertisement

Comments are closed.